Development stage biotechnology company ARYx Therapeutics Inc has announced on Wednesday that they have already reached the financing agreement and may sell up to US$ 35 million of its shares to Commerce Court Small Cap …

ADVENTRX Pharmaceuticals have announced that they have received license to purchase shares of its Series D convertible preferred stock pursuant to registered direct offering to institutional investors that will represent gross proceeds to ADVENTRX of …